For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
The biosensor is a sensing device, which consists of a combination of a specific biological element and a transducer. Biosensors are defined as analytical devices that convert a biological response into electrical signal and assist in measuring a wide spectrum of analytes including organic compounds, gases, bacteria and others.
Scope of the Report:
This report focuses on the Glucose Biosensors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
At present, in developed countries, the glucose biosensors industry is generally at a more advanced level. The world's large enterprises are mainly concentrated in USA and Europe. Meanwhile, foreign companies have more advanced equipment, strong R & D capability, and leading technical level. However, foreign companies' manufacturing cost is relatively higher, compared with Chinese companies. With the development of Chinese glucose biosensors production technology, their share in the international market is increasing, and competitiveness in the international market gradually increases.
Although glucose biosensors brings a lot of opportunities, the study group recommends the new entrants just having money but without technical advantage and upstream and downstream support do not to enter into this field.
The worldwide market for Glucose Biosensors is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 3440 million US$ in 2023, from 3120 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- - Roche
- - LifeScan
- - Bayer
- - Abbott
- - ARKRAY
- - Omron
- - I-SENS
- - B. Braun
- - Dexcom
- - AgaMatrix
- - SANNUO
- - YICHENG
- - Yuwell
- - Andon Health
- - Yingke
Market Segment by Regions, regional analysis covers
- - North America (United States, Canada and Mexico)
- - Europe (Germany, France, UK, Russia and Italy)
- - Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- - South America (Brazil, Argentina, Colombia etc.)
- - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- - Self-monitoring of blood glucose (SMBG)
- - Continuous Glucose Monitoring Systems
Market Segment by Applications, can be divided into
- - Homecare diagnostics
- - Hospitals
- - Diagnostic Centers, Clinics
- - Other
There are 15 Chapters to deeply display the global Glucose Biosensors market.
Chapter 1, to describe Glucose Biosensors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Glucose Biosensors, with sales, revenue, and price of Glucose Biosensors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Glucose Biosensors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Glucose Biosensors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Glucose Biosensors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source